Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

March 18th, 2024

Melbourne, Australia

Event Type:

In-Person

This BioSymposium will explore the complex AI landscape. What are the ethical and practical challenges of using this technology to diagnose conditions and make treatment recommendations? When is AI integration compulsory and who bears responsibility? And what potential sanctions are imminent for non-use?

Iñaki Berasategui

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

Event Website

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

March 18th, 2024

–

Event Type: In-Person

This BioSymposium will explore the complex AI landscape. What are the ethical and practical challenges of using this technology to diagnose conditions and make treatment recommendations? When is AI integration compulsory and who bears responsibility? And what potential sanctions are imminent for non-use? Meet with Iñaki Berasategui, Business Development Director.

Attending

Nate Zhang

VP, Taimei Technology

GM, Clinical Research and Overseas Business

CEO, Taimei Technology US

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

Melbourne, Australia

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

March 18th, 2024

–

Event Type: In-Person

Attending

Nate Zhang

VP, Taimei Technology

GM, Clinical Research and Overseas Business

CEO, Taimei Technology US

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

Melbourne, Australia

This listing has been expired.